Mission statement

“Targeted therapy stops the bleeding.” This quintessence orientates itself on our customers and pushes our action.

We aim to improve patient outcome following trauma, transplantation or heart surgery as well as reducing the general cost of treatment and usage of blood products through differential diagnosis, targeted therapy and monitoring.

We do this through the development, manufacture and sales of medical diagnostic devices designed to manage acute and massive bleeding situations at the patients point of care.

We aim to understand our customers needs through the regular exchange of information with key opinion leaders, distribution partners and customers themselves. Through this we develop new products and services suited to those specific customer requirements.